How Customers Are Advancing Clinical Trials with Medidata
More than 2,200 life sciences organizations use Medidata to run faster, smarter, and more connected trials. See how customers are improving clinical operations, strengthening data quality, engaging patients, and applying AI across the clinical lifecycle.
Success Stories
The Power of a Unified Platform
"We value having a unified platform utilizing Medidata's multiple systems, not only EDC, but RTSM, the adjudication, and what that is doing for our sites is it gives them a very similar platform. They're able to go in, they see the same areas, they feel very comfortable, and that's a really low burden for the site."
Enabling a Holistic View of Clinical Data
"Looking at Clinical Data Studio, the primary value is clean … data… faster. It’s very simple, very straightforward, and very powerful. Having that context, of all the clinical data, all of the endpoint data, in one place regardless of underlying system, it moves the needle."
Pivotal Shift to Integrated Data Management
"We use a suite of products from Medidata and for us it’s such a valuable experience, changing how we approach our data and how we integrate our data. The word transformative keeps coming up but it truly is for us."
Accelerating Development Timelines and Boosting Efficiency with AI Integration.
"The adoption of Meidata Designer was absolutely fundamental for us because we develop all our CRFs in-house. With Designer, we could accelerate timelines and make our process more efficient."
Adaptable Tools to Meet End User Capabilities
"Medidata is known for constantly looking for how it can do the next thing better than everyone else. And by being partners with Medidata, it gives us that ability too."
Spotlight Stories
Here’s how next generation data management helped REZOLUTE accelerate completion of a complex trial
What Our Customers Are Saying
"The one thing that I find the most valuable with the relationship with Medidata is it's a very direct and transparent conversation. It is a give and take... it's a constant open dialogue and it's collaborative in nature."
Amy Plodek, BS, MHA
Senior Director, Clinical Data Management
"We use trusted partners like Medidata for tool sets to drive the AI narrative. With the way the market is going, it is too risky not to partner with Medidata on the full clinical platform."
Carmen Stiles
SVP, Global Analytics
“Having a unified platform really cuts down on the number of workflows that you normally would have to have when you're using multiple vendors. Data is flowing through the one system. You have the traceability at your hand. You're removing two or three steps. All that documentation flows - removing the redundancy from multiple systems. It allows us to be efficient, keep costs down for us and our clients.”
Mike Mendoza
VP, Biometrics and Data Science
“Medidata is a global brand that everyone knows, and everyone is happy to use… The seamless experience … creates a much easier experience for us. Sites are entering data very quickly. They know the system and they know these modules back and forth. They don’t have a lot of questions. And there’s a lot of confidence in that.”
Karis Oasan
A. Director Clinical Affairs
“Medidata is a global brand that everyone knows, and everyone is happy to use… The seamless experience … creates a much easier experience for us. Sites are entering data very quickly. They know the system and they know these modules back and forth. They don’t have a lot of questions. And there’s a lot of confidence in that.”
Heidi Varghese
Director of Finance
“… Our partnership with Medidata has been very collaborative from a data management perspective in rolling out all the new applications and tools and integrating them with EDC. It’s made data management easier for reviewing the data, drawing out metrics, and building the forms. It’s an easier platform to design and then work with integrating new tools like RTSM or eCOA/ePRO.”
Cathy Hult
Director of Data Management
“The effect that we have seen is the achievement of end of study and ‘on to market’ times reducing rapidly from ten years to an average of six years; shrinking end-of-study times by four years translates to faster delivery of new treatments to patients in need.”
Dilshat Djumanov
Director of Data Science
In the News
Worldwide Clinical Trials and Medidata Announce Strategic Partnership to Embed Medidata AI Across the Full Trial Lifecycle, Bolstering Study Execution and Delivery Excellence
Medidata Expands Partnership with The Menarini Group, Deploying Medidata’s Study Build AI Technology to Accelerate Global Oncology Pipeline
Medidata Expands Collaboration with CTI Clinical Trial and Consulting, Shaping a New Era of Patient-Centric Studies
Caidya Reimagines Next Generation Clinical Trial Innovation and Study Delivery with Medidata AI‑powered Experiences
Medidata and the National Cancer Institute Extend 15-year Partnership for an Additional Five Years
Medidata and Sanofi Vaccines Extend Collaboration to Improve Patient Centricity and Trial Efficiency